Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
252.20    -1.60 (-0.63%)
Bid:
252.00
Ask:
252.20
Spread: 0.20 (0.079%)
Market Cap: £2.49b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Share Repurchase Programme

5 Mar 2026 07:02

RNS Number : 4039V
Serco Group PLC
05 March 2026
 

LEI: 549300PT2CIHYN5GWJ21

5 March 2026

Serco Group plc

Share Repurchase Programme

 

Serco Group plc (the Company) today announces that, as outlined in the announcement of its 2026 Full Year Results on 5 March 2026, it intends to repurchase shares with a value of up to £75 million (the Programme).

 

This will occur during the period starting on 9 March 2026 and ending no later than 31 July 2026 (the Engagement Period). The aggregate number of shares acquired by the Company shall not exceed the balance of 81,273,394 shares remaining of the 102,385,524 shares authorised by shareholders at the 2025 Annual General Meeting. It is intended that any shares repurchased under the Programme will be transferred into treasury and subsequently cancelled.

 

The Company has entered into an agreement with RBC Europe Limited (RBC) under which RBC will manage the Programme for the Engagement Period. RBC will carry out the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. RBC will make trading decisions in relation to the Programme independently of the Company. During any closed periods, the Company will have no power to invoke any changes to the Programme, and it will be executed at the sole discretion of RBC. This arrangement is in accordance with Chapter 9 of the Financial Conduct Authority's Listing Rules and the Company's general authority to repurchase shares.

 

The Programme will also be conducted in accordance with the parameters of the safe harbour provisions set out in: (i) Article 5(1) of Regulation (EU) 596/2014 (including the delegated and implementing acts adopted under it); and (ii) the provisions of Commission Delegated Regulation (EU) 2016/1052 with regard to regulatory technical standards for the conditions applicable to buyback programmes and stabilisation measures (in each case as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as implemented, retained, amended, extended, re-enacted or otherwise given effect. There is no guarantee that the Programme will be implemented in full.

 

The Company intends to announce any purchase of Ordinary Shares under the Programme in line with the Financial Conduct Authority's Listing Rule 9.6.6, by no later than the end of the 7th daily market session following the date of execution of such purchase.

 

Ends

 

For further information please contact:

 

Jamie Hastings, Head of Investor Relations | +44 (0) 7718 195 074 | jamie.hastings@serco.com

Scot Marchbank, External Communications and Director | +44 (0) 7958 675 706 | scot.marchbank@serco.com

 

 

About Serco

Serco brings together the right people, the right technology, and the right partners to create innovative solutions that make a positive impact and address some of the most urgent and complex challenges facing the modern world.

 

With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility, and customer services.

 

Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management.

 

Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery.

 

More information can be found at www.serco.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSAORNBUORUR
Date   Source Headline
5th Jun 20265:36 pmRNSTransaction in Own Shares
29th May 20265:35 pmRNSTransaction in Own Shares and Total Voting Rights
26th May 20267:00 amRNSSerco secures £270m contract from NNUH
22nd May 20265:14 pmRNSTransaction in Own Shares
15th May 20265:24 pmRNSTransaction in Own Shares
8th May 20265:25 pmRNSTransaction in Own Shares
30th Apr 20265:37 pmRNSTransactions in own shares and Total Voting Rights
24th Apr 20265:17 pmRNSTransactions in Own Shares
22nd Apr 20264:00 pmRNSResult of AGM
17th Apr 20265:34 pmRNSTransactions in Own Shares
10th Apr 20265:39 pmRNSTransactions in Own Shares
10th Apr 20263:46 pmRNSDirector/PDMR Shareholding
7th Apr 20265:35 pmRNSDirector/PDMR Shareholding
31st Mar 20265:21 pmRNSTransactions in Own Shares and Total Voting Rights
27th Mar 20263:03 pmRNSDirector/PDMR Shareholding
20th Mar 20265:50 pmRNSTransaction in Own Shares
18th Mar 20265:15 pmRNSHolding(s) in Company
18th Mar 202611:00 amRNSPublication of the 2025 ARA and 2026 Notice of AGM
13th Mar 20265:25 pmRNSTransaction in Own Shares
11th Mar 20265:46 pmRNSTransaction in Own Shares and Total Voting Rights
5th Mar 20267:02 amRNSShare Repurchase Programme
5th Mar 20267:00 amRNS2025 full year results
19th Feb 20265:45 pmRNSHolding(s) in Company
9th Feb 20265:30 pmRNSHolding(s) in Company
5th Feb 202612:30 pmRNSHolding(s) in Company
2nd Feb 20265:45 pmRNSTotal Voting Rights and Capital
29th Jan 20265:30 pmRNSHolding(s) in Company
5th Jan 20265:30 pmRNSHolding(s) in Company
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
23rd Dec 20254:00 pmRNSHolding(s) in Company
23rd Dec 20254:00 pmRNSHolding(s) in Company
19th Dec 20257:30 amRNSCancellation of Treasury Shares
19th Dec 20257:30 amRNSCancellation of Treasury Shares
17th Dec 20257:01 amRNSCFO Retirement
17th Dec 20257:00 amRNSSerco pre-close trading update
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:30 pmRNSBlock listing Interim Review
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSSerco awarded UK prison contract
28th Nov 20256:20 pmRNSTransactions in own shares and Total Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.